PubRank

Kurt R Zinn

Author PubWeight™ 72.58‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Live dynamic imaging of caveolae pumping targeted antibody rapidly and specifically across endothelium in the lung. Nat Biotechnol 2007 3.54
2 Expansion of spleen myeloid suppressor cells represses NK cell cytotoxicity in tumor-bearing host. Blood 2007 2.35
3 Preclinical comparison of near-infrared-labeled cetuximab and panitumumab for optical imaging of head and neck squamous cell carcinoma. Mol Imaging Biol 2013 1.67
4 In vivo molecular chemotherapy and noninvasive imaging with an infectivity-enhanced adenovirus. J Natl Cancer Inst 2002 1.61
5 Stereomicroscopic fluorescence imaging of head and neck cancer xenografts targeting CD147. Cancer Biol Ther 2008 1.57
6 Use of fluorescent labeled anti-epidermal growth factor receptor antibody to image head and neck squamous cell carcinoma xenografts. Mol Cancer Ther 2007 1.52
7 Enhanced therapeutic efficacy for ovarian cancer with a serotype 3 receptor-targeted oncolytic adenovirus. Mol Ther 2003 1.43
8 Fluorescent labeled anti-EGFR antibody for identification of regional and distant metastasis in a preclinical xenograft model. Head Neck 2008 1.42
9 Prevention of diabetic nephropathy in Ins2(+/)⁻(AkitaJ) mice by the mitochondria-targeted therapy MitoQ. Biochem J 2010 1.40
10 Fc gamma Rs modulate cytotoxicity of anti-Fas antibodies: implications for agonistic antibody-based therapeutics. J Immunol 2003 1.33
11 Use of panitumumab-IRDye800 to image microscopic head and neck cancer in an orthotopic surgical model. Ann Surg Oncol 2012 1.30
12 Breast tumor xenografts: diffusion-weighted MR imaging to assess early therapy with novel apoptosis-inducing anti-DR5 antibody. Radiology 2008 1.20
13 A triple-targeted ultrasound contrast agent provides improved localization to tumor vasculature. J Ultrasound Med 2011 1.19
14 TRA-8 anti-DR5 monoclonal antibody and gemcitabine induce apoptosis and inhibit radiologically validated orthotopic pancreatic tumor growth. Mol Cancer Ther 2007 1.18
15 Early therapy evaluation of combined anti-death receptor 5 antibody and gemcitabine in orthotopic pancreatic tumor xenografts by diffusion-weighted magnetic resonance imaging. Cancer Res 2008 1.17
16 Combination treatment with TRA-8 anti death receptor 5 antibody and CPT-11 induces tumor regression in an orthotopic model of pancreatic cancer. Clin Cancer Res 2007 1.14
17 Determination of breast cancer response to bevacizumab therapy using contrast-enhanced ultrasound and artificial neural networks. J Ultrasound Med 2010 1.11
18 Gammadelta T cells in EAE: early trafficking events and cytokine requirements. Eur J Immunol 2009 1.07
19 DCE-MRI detects early vascular response in breast tumor xenografts following anti-DR5 therapy. Mol Imaging Biol 2011 1.07
20 Fluorescently labeled therapeutic antibodies for detection of microscopic melanoma. Laryngoscope 2013 1.04
21 A phase I clinical trial of Ad5.SSTR/TK.RGD, a novel infectivity-enhanced bicistronic adenovirus, in patients with recurrent gynecologic cancer. Clin Cancer Res 2012 1.04
22 Detection of early changes in renal function using 99mTc-MAG3 imaging in a murine model of ischemia-reperfusion injury. Am J Physiol Renal Physiol 2007 1.03
23 Tamoxifen inhibits malignant peripheral nerve sheath tumor growth in an estrogen receptor-independent manner. Neuro Oncol 2010 1.02
24 Deficiency of P-selectin or P-selectin glycoprotein ligand-1 leads to accelerated development of glomerulonephritis and increased expression of CC chemokine ligand 2 in lupus-prone mice. J Immunol 2006 1.02
25 Endotoxin-induced proteolytic reduction in hepatic growth hormone (GH) receptor: a novel mechanism for GH insensitivity. Mol Endocrinol 2008 0.99
26 Deletion of IGF-I receptor (IGF-IR) in primary osteoblasts reduces GH-induced STAT5 signaling. Mol Endocrinol 2010 0.99
27 Use of panitumumab-IRDye800 to image cutaneous head and neck cancer in mice. Otolaryngol Head Neck Surg 2013 0.97
28 The status of contemporary image-guided modalities in oncologic surgery. Ann Surg 2015 0.97
29 Dual combination therapy targeting DR5 and EMMPRIN in pancreatic adenocarcinoma. Mol Cancer Ther 2011 0.97
30 Treatment of human colon cancer xenografts with TRA-8 anti-death receptor 5 antibody alone or in combination with CPT-11. Clin Cancer Res 2008 0.97
31 (18)F-FDG PET/CT imaging detects therapy efficacy of anti-EMMPRIN antibody and gemcitabine in orthotopic pancreatic tumor xenografts. Mol Imaging Biol 2012 0.96
32 Targeted radiotherapy with [(90)Y]-SMT 487 in mice bearing human nonsmall cell lung tumor xenografts induced to express human somatostatin receptor subtype 2 with an adenoviral vector. Cancer 2002 0.95
33 High-resolution single-photon emission computed tomography and X-ray computed tomography imaging of Tc-99m-labeled anti-DR5 antibody in breast tumor xenografts. Mol Cancer Ther 2007 0.95
34 Optical imaging predicts tumor response to anti-EGFR therapy. Cancer Biol Ther 2010 0.93
35 Identification of the optimal therapeutic antibody for fluorescent imaging of cutaneous squamous cell carcinoma. Cancer Biol Ther 2013 0.92
36 Early therapy evaluation of combined cetuximab and irinotecan in orthotopic pancreatic tumor xenografts by dynamic contrast-enhanced magnetic resonance imaging. Mol Imaging 2011 0.92
37 Systemic osteoprotegerin gene therapy restores tumor-induced bone loss in a therapeutic model of breast cancer bone metastasis. Mol Ther 2008 0.91
38 Novel infectivity-enhanced oncolytic adenovirus with a capsid-incorporated dual-imaging moiety for monitoring virotherapy in ovarian cancer. Mol Imaging 2009 0.90
39 In vivo imaging of hepatic growth hormone signaling. Mol Endocrinol 2006 0.90
40 Effect of anti-DR5 and chemotherapy on basal-like breast cancer. Breast Cancer Res Treat 2011 0.90
41 Extracelluar matrix metalloproteinase as a novel target for pancreatic cancer therapy. Anticancer Drugs 2011 0.89
42 Putting numbers to fluorescent guided surgery. Mol Imaging Biol 2013 0.88
43 Genetic modification of adeno-associated viral vector type 2 capsid enhances gene transfer efficiency in polarized human airway epithelial cells. Hum Gene Ther 2008 0.87
44 Effector and suppressor roles for LFA-1 during the development of experimental autoimmune encephalomyelitis. J Neuroimmunol 2008 0.87
45 Neural progenitor cell transplantation and imaging in a large animal model. Neurosci Res 2007 0.87
46 Enhancement of MHC class II-restricted responses by receptor-mediated uptake of peptide antigens. J Immunol 2002 0.87
47 Optical fluorescent imaging to monitor temporal effects of microbubble-mediated ultrasound therapy. IEEE Trans Ultrason Ferroelectr Freq Control 2013 0.85
48 Radiotargeted gene therapy. J Nucl Med 2005 0.85
49 Blood-based screening and light based imaging for the early detection and monitoring of ovarian cancer xenografts. Technol Cancer Res Treat 2003 0.85
50 Bioluminescence-based visualization of CD4 T cell dynamics using a T lineage-specific luciferase transgenic model. BMC Immunol 2009 0.84
51 Noninvasive monitoring of mRFP1- and mCherry-labeled oncolytic adenoviruses in an orthotopic breast cancer model by spectral imaging. Mol Imaging 2010 0.84
52 Orthotopic xenografting of human luciferase-tagged malignant peripheral nerve sheath tumor cells for in vivo testing of candidate therapeutic agents. J Vis Exp 2011 0.83
53 Antagonistic effects of anti-EMMPRIN antibody when combined with chemotherapy against hypovascular pancreatic cancers. Mol Imaging Biol 2013 0.82
54 Model system using controlled receptor expression for evaluating targeted ultrasound contrast agents. Ultrasound Med Biol 2011 0.82
55 A novel extracellular drug conjugate significantly inhibits head and neck squamous cell carcinoma. Oral Oncol 2013 0.82
56 Inhibitory GH receptor extracellular domain monoclonal antibodies: three-dimensional epitope mapping. Endocrinology 2011 0.82
57 Early therapy assessment of combined anti-DR5 antibody and carboplatin in triple-negative breast cancer xenografts in mice using diffusion-weighted imaging and (1)H MR spectroscopy. J Magn Reson Imaging 2013 0.82
58 Enhancement of adenovirus delivery after ultrasound-stimulated therapy in a cancer model. Ultrasound Med Biol 2013 0.81
59 Targeting of adenovirus serotype 5 pseudotyped with short fiber from serotype 41 to c-erbB2-positive cells using bispecific single-chain diabody. J Mol Biol 2009 0.80
60 An animal model allowing controlled receptor expression for molecular ultrasound imaging. Ultrasound Med Biol 2012 0.80
61 Single photon emission computed tomography demonstrated efficacy of 17β-estradiol therapy in male rats after trauma-hemorrhage and extended hypotension. J Trauma 2010 0.80
62 Intraperitoneal pretarget radioimmunotherapy with CC49 fusion protein. Clin Cancer Res 2005 0.79
63 Gene expression imaging with radiolabeled peptides. Ann Nucl Med 2004 0.79
64 Dynamic analysis of GH receptor conformational changes by split luciferase complementation. Mol Endocrinol 2014 0.78
65 Biodistribution of P-selectin targeted microbubbles. J Drug Target 2014 0.78
66 A non-invasive approach for monitoring breast tumor cells during therapeutic intervention. Cancer Biother Radiopharm 2002 0.78
67 Death receptor 5 agonist TRA8 in combination with the bisphosphonate zoledronic acid attenuated the growth of breast cancer metastasis. Cancer Biol Ther 2009 0.78
68 Alternatively spliced FGFR-1 isoform signaling differentially modulates endothelial cell responses to peroxynitrite. Arch Biochem Biophys 2003 0.77
69 Human GH receptor-IGF-1 receptor interaction: implications for GH signaling. Mol Endocrinol 2014 0.76
70 Inhibition of T cell responses by transferrin-coupled competitor peptides. Immunol Res 2002 0.75
71 Oncologic Procedures Amenable to Fluorescence-guided Surgery. Ann Surg 2016 0.75